Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL JOEL GUREVITCH

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1629016894
CMS profile
345551
Location
PASADENA, CA

General Payments · PY2018–2024

$7,235.15

  • Reported across 284 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,075.03

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $550.03 15
Consulting Fee $525.00 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,270.83 63
PY2019 $2,153.93 100
PY2020 $866.54 43
PY2021 $519.39 26
PY2022 $760.30 17
PY2023 $589.13 19
PY2024 $1,075.03 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $140.56 03/06/2024 Food and Beverage Undisputed 01/23/2026 1125157300 CMS
Abbott Laboratories $6.09 03/19/2024 Food and Beverage Undisputed 01/23/2026 1125157302 CMS
AstraZeneca Pharmaceuticals LP $24.30 08/15/2024 Food and Beverage Undisputed 01/23/2026 1105479767 CMS
AstraZeneca Pharmaceuticals LP $19.75 10/15/2024 Food and Beverage Undisputed 01/23/2026 1105781552 CMS
Fisher & Paykel Healthcare Limited $525.00 07/30/2024 Consulting Fee Undisputed 01/23/2026 1138737512 CMS
GlaxoSmithKline, LLC. $22.66 01/18/2024 Food and Beverage Undisputed 01/23/2026 1116110270 CMS
GlaxoSmithKline, LLC. $22.30 03/14/2024 Food and Beverage Undisputed 01/23/2026 1116303267 CMS
GlaxoSmithKline, LLC. $22.14 05/21/2024 Food and Beverage Undisputed 01/23/2026 1116317816 CMS
GlaxoSmithKline, LLC. $23.22 06/11/2024 Food and Beverage Undisputed 01/23/2026 1116153750 CMS
GlaxoSmithKline, LLC. $21.62 07/16/2024 Food and Beverage Undisputed 01/23/2026 1116648911 CMS
GlaxoSmithKline, LLC. $20.03 12/10/2024 Food and Beverage Undisputed 01/23/2026 1115995627 CMS
Mylan Specialty L.P. $22.43 03/05/2024 Food and Beverage Undisputed 01/23/2026 1147325046 CMS
Mylan Specialty L.P. $16.67 09/10/2024 Food and Beverage Undisputed 01/23/2026 1147295645 CMS
Teleflex LLC $15.63 01/29/2024 Food and Beverage Undisputed 01/23/2026 1142074565 CMS
Teleflex LLC $147.04 02/27/2024 Food and Beverage Undisputed 01/23/2026 1142091485 CMS
United Therapeutics Corporation $25.59 01/09/2024 Food and Beverage Undisputed 01/23/2026 1149449942 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.